Abstract
Clinical practice guidelines (CPG) are systematic statements designed to help physicians and patients in taking decisions about appropriate care for specific clinical circumstances. The goals of CPG include reducing the unjustified variation in medical practice, improve the quality of health care, and accelerate adoption of effective interventions. The design of diabetes guidelines has nurtured from the principles of evidence-based medicine and from the results of randomized clinical trials in the pursuit of improvement in clinical outcomes, with a shift from universal recommendations to all patients to a patient-centered approach. Recognition of the impact of unjustified variations of medical practice on clinical outcomes, health-care costs, and patient’s priorities is becoming increasingly relevant in the design of diabetes clinical guidelines. Strategies to reinforce implementation include audit, feedback, and reminders, but challenges of awareness, acceptance, and measurement are still formidable.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Glover JA. The incidence of tonsillectomy in school children. Int J Epidemiol. 2008;37:9–19.
Brownlee S. From Pariah to Pioneer. Dartmouth Med. Fall, 2013:22–9.
Brownlee S. Overtreated. Why too much medicine is making us sicker and poorer. Bloomsbury: New York; 2007.
Wennberg JE. Forty years of unwarranted variation – and still counting. Health Policy. 2014;114:1–2.
Wennberg JE. Tracking medicine. A researcher’s quest to understand health care. New York: Oxford University Press; 2010.
Wennberg J, Gittelsohn A. Small area variations in health care delivery: a population-based health information system can guide planning and regulatory decision making. Science. 1973;182:1102–8.
Wennberg J, Gittelsohn A. Variations in medical care among small areas. Sci Am. 1982;246:120–34.
Chassin MR, Brook RH, Park RE, Keesey J, Fink A, Kosecoff J, et al. Variations in the use of medical and surgical services by the Medicare population. N Engl J Med. 1986;314:285–90.
Gittelsohn A, Powe NR. Small area variations in health care delivery in Maryland. Health Serv Res. 1995;30:295–317.
Pasley B, Gibson G, McCauley M, Andoh J. Geographic variations in elderly hospital and surgical discharge rates, New York State. Am J Public Health. 1987;77:679–84.
Mackenbach JP. Regional differences in the frequency of various common surgical procedures, 1985. Ned Tijdschr Geneeskd. 1990;134:953–7.
Welch WP, Miller ME, Welch HG, Fisher ES, Wennberg JE. Geographic variation in expenditures for physicians’ services in the United States. N Engl J Med. 1993;328:621–7.
Birkmeyer JD, Reames BN, McCulloch P, Carr AJ, Campbell WB, Wennberg JE. Understanding of regional variation in the use of surgery. Lancet. 2013;382:1121–9.
Koval KJ, Lurie J, Zhou W, Sparks MB, Cantu RV, Sporer SM, Weinstein J. Ankle fractures in the elderly: what you get depends on where you live and who you see. J Orthop Trauma. 2005;19:635–9.
Detsky AS. Regional variation in medical care. N Engl J Med. 1995;333:589–90.
Fuchs VR. More variation in use of care, more flat-of-the curve medicine. Health Aff. 2004;Suppl Variation:VAR104–7.
Eddy DM. Clinical policies and the quality of clinical practice. N Engl J Med. 1982;307:343–7.
Brook RH. Practice guidelines and practicing medicine. Are they compatible? JAMA. 1989;262:3027–30.
No authors listed. Guidelines for doctors in the new world. Lancet, 1992;339:1197–1198.
Onion CWR, Walley T. Clinical guidelines: development, implementation, and effectiveness. Postgrad Med J. 1995;71:3–9.
Manchikanti L. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management, part I: introduction and general considerations. Pain Physician. 2008;11:161–86.
Mullan F, Jacoby I. The town meeting for technology. The maturation of consensus conferences. JAMA. 1985;254:1068–72.
Grant WR. Critical pathways in medicine. Proc Roy Soc Med. 1970;63:671–3.
Pearson SD, Goulart-Fisher D, Lee TH. Critical pathways as a strategy for improving care: problems and potential. Ann Intern Med. 1995;123:941–8.
Greenfield S, Lewis CE, Kaplan SH. Peer review by criteria mapping: criteria for diabetes mellitus. Ann Intern Med. 1975;83:761–70.
Coffey RJ, Richards JS, Remmert CS, LeRoy SS, Schoville RR, Baldwin PJ. An introduction to critical paths. Qual Manag Health Care. 1992;1:45–54.
Field MJ, Lohr KN. Guidelines for clinical practice. From development to use. Washington, D.C.: National Academies Press; 1992.
Agency for Health Care Policy Research. Using clinical practice guidelines to evaluate quality of care. Rockville Maryland AHCPR Pub., No. 95–0045. 1995.
Margolis CZ. Clinical practice guidelines: methodological considerations. Int J Quality Health Care. 1997;9:303–6.
Huttin C. The use of clinical guidelines to improve medical practice: main issues in the United States. Int J Qual Health Care. 1997;9:207–41.
Eddy DM. Practice policies – what are they? JAMA. 1990;263:877–80.
Eddy DM. Practice policies: where do they come from? JAMA. 1990;263:1265, 1269, 1272, 1275.
Eddy DM. Practice policies- guidelines for methods. JAMA. 1990;263:1839–41.
Eddy DM. Guidelines for policy statements: the explicit approach. JAMA. 1990;263:2239–40, 2243.
Eddy DM. Designing a practice policy. Standards, guidelines and options. JAMA. 1990;263:3077, 3081, 3084.
Eddy DM. Assessing health practices & designing practice policies. The explicit approach. American College of Physicians: Philadelphia PA; 1992. p. 1–126.
Agency for Health Care Policy and Research. Clinical guideline development. Rockville: Agency for Health Care Policy and Research; 1990.
Woolf SH. Manual for clinical practice guideline development: a protocol for expert panels convened by the Office of the Forum for quality and effectiveness in health care. Rockville: DHHS, PHS, Agency for Health Care Policy and Research (AHCPR) Center for Research Dissemination and Liaison; 1991.
Spernak SM, Budetti PP, Zweig F. Use of language in clinical practice guidelines. Rockville: Center for Health Policy Research; 1992.
Department of Veterans Affairs. Veterans Health Administration. Roles and definitions for clinical practice guidelines and clinical pathways. Washington, D.C.; 1996.
Kirk JK, Michael KA, Markosky SJ, Restino MR, Zarowitz BJ. Critical pathways: the time is here for pharmacist involvement. Pharmacotherapy. 1996;16:723–33.
Ritchie JL, Forrester JS, Fye WB. 28th Bethesda conference: practice guidelines and the quality of care. JACC. 1997;29:1125–79.
Jackson R, Feder G. Guidelines for clinical guidelines. A simple, pragmatic survey for guideline development. BMJ. 1998;317:427–8.
Investigations JD. How to get from guidelines to protocols. Firstly, collect the right data. BMJ. 1991;303:323–4.
Woolf SH. Practice guidelines: a new reality in medicine. I Recent developments. Arch Intern Med. 1990;150:1811–8.
Woolf SH. Practice guidelines, a new reality in medicine. II Methods of developing guidelines. Arch Intern Med. 1992;152:946–52.
Feder G. Which guidelines to follow? BMJ. 1994;308:470–1.
Hadorn DC, Baker D, Hodges JS, Hicks N. Rating the quality of evidence for clinical practice guidelines. J Clin Epidemiol. 1996;49:749–54.
Guallar E, Laine C. Controversy over clinical guidelines: listen to the evidence, not the noise. Ann Intern Med. 2014;160:361–2.
Woolf SH. Do clinical practice guidelines define good medical care? The need for good science and the disclosure of uncertainty when defining “best practices”. Chest. 1998;113:166S–71S.
Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Developing guidelines. BMJ. 1999;318:593–6.
Every NR, Hochman J, Becker R, Kopecky S, Cannon CP. Critical pathways. A review. Circulation. 2000;101:461–5.
Berg AO, Atkins D, Tierney W. Clinical practice guidelines in practice and education. J Gen Int Med. 1997;12(suppl 2):S25–33.
Sox HC, Sox CH, Tompkins RK. The training of physician’s assistants: the use of a clinical algorithm system for patient care, audit of performance and education. N Engl J Med. 1973;288:818–24.
Sox HC. On standardization of clinical algorithms. Proposal for clinical algorithm standards. Med. Decis Making. 1992;12:149–54.
Weingarten S. Practice guidelines and prediction rules should be subject to careful clinical testing. JAMA. 1997;277:1977–8.
Berwick DM. Continuous improvement as an ideal in health care. N Engl J Med. 1989;320:53–6.
Heffner JE, Alberts M, Irwin R, Wunderink R. Translating guidelines into clinical practice. Recommendations to the American College of Chest Physicians. Chest. 2000;118:70S–3S.
Eccles M, Mason J. Executive summary. How to develop cost-conscious guidelines. Health Technol Assess. 2001:5(16).
Haycox A, Bagust A, Walley T. Clinical guidelines-the hidden costs. BMJ. 1999;318:391–3.
Eccles MP, Grimshaw JM, Shekelle P, Schünemann J, Woolf S. Developing clinical practice guidelines: target audiences, identifying topics for guidelines, guideline group composition and functioning and conflicts of interest. Implement Sci. 2012;7:60.
Grimshaw JM, Russell IT. Achieving health gain through clinical guidelines II: ensuring guidelines change medical practice. Qual Health Care. 1994;3:45–52.
Eccles M, Freemantle N, Mason J. North of England evidence based guidelines development project: methods of developing guidelines for efficient drug use in primary care. BMJ. 1998;316:1232–5.
Weingarten S. How to judge practice guidelines. WJM. 1999;170:352.
Barton S. Using clinical evidence. Having the evidence in your hand is just a start – but a good one. BMJ. 2001;322:503–4.
Shekelle PG, Ortiz E, Rhodes S, Morton SC, Eccles MP, Grimshaw JM, Woolf SH. Validity of the Agency for Healthcare Research and Quality clinical practice guidelines. How quickly do clinical guidelines become outdated? JAMA. 2001;286:1461–7.
Shekelle P, Eccles J, Grimshaw JM, Woolf SH. When should clinical guidelines be updated? BMJ. 2001;323:155–7.
Woolf S, Schünemann HJ, Eccles MP, Graimshaw JM, Shekelle P. Developing clinical practice guidelines: types of evidence and outcomes; values and economics, synthesis, grading, and presentation and deriving recommendations. Implement Sci. 2012;7:61.
Shekelle P, Woolf S, Grimsahw JM, Schünemann HJ, Eccles MP. Developing clinical guidelines: reviewing, reporting, and publishing guidelines; updating guidelines; and the emerging issues of enhancing guideline implementability and accounting for comorbid conditions in guideline development. Implement Sci. 2012;7:62.
Grol R. Implementing guidelines in general practice care. Qual Health Care. 1992;1:184–91.
Feder G, Eccles M, Grol R, Griffins C, Grimshaw J. Using clinical guidelines. BMJ. 1999;318:728–30.
Grimshaw J, Freemantle N, Wallace S, Russell I, Hurwitz I, Watt I, Long A, Sheldon T. Developing and implementing clinical practice guidelines. Qual Health Care. 1995;4:55–64.
Conroy M, Shannon W. Clinical guidelines: their implementation in general practice. Br J Gen Pract. 1995;45:371–5.
Forrest D, Hoskins A, Hussey R. Clinical guidelines and their implementation. Postgrad Med J. 1996;72:19–22.
Wensing M, Van der Weijden T, Grol R. Implementing guidelines and innovations in general practice: which interventions are effective? Br J Gen Pract. 1998;48:991–7.
Freemantle N. Implementation strategies. Fam Pract. 2000;17(Suppl 1):S7–S10.
Gundersen L. The Efect of clinical practice guidelines on variations in care. Ann Intern Med. 2000;133:317–8.
Heffner JE. The Overaching challenge. Chest. 2000;118:1S–3S.
Weingarten S. Translating practice guidelines into patient care. Guidelines at the bedside. Chest. 2000;118:4S–7S.
Smith WR. Evidence for the effectiveness of techniques to change physician behavior. Chest. 2000;118:8S–17S.
Slotnick HB. Physicians’ learning strategies. Chest. 2000;118:18S–23S.
Borbas C, Morris N, McLaughlin B, Asinger R, Gobel F. The role of clinical leaders in guideline implementation and quality improvement. Chest. 2000;118:24S–32S.
Ockene JK, Zapka JG. Provider education to promote implementation of clinical practice guidelines. Chest. 2000;118:33S–9S.
Curry SJ. Organizational interventions to encourage guideline implementation. Chest. 2000;118:40S–6S.
Payne TH. Computer support systems. Chest. 2000;118:47S–52S.
Weiss KB, Wagner R. Performance measurement through audit, feedback, and profiling as tools for improving clinical care. Chest. 2000;118:53S–8S.
Tillotson GS. Implementation and physician behavior change. An industry perspective. Chest. 2000;118:59S–61S.
Crim C. Clinical practice guidelines vs actual clinical practice. The asthma paradigm. Chest. 2000;118:62–64S.
Mitchell JP. Guideline implementation in the Department of Defense. Chest. 2000;118:65S–9S.
Grol R. Beliefs and evidence in changing clinical practice. BMJ. 1997;315:418–21.
Haines A, Feder G. Guidance on guidelines. Writing them is easier than making them work. BMJ. 1992;305:785–6.
Durieux P, Ravaud P. From clinical guidelines to quality assurance: the experience of assistance Publique-Hospitaux de Paris. Int J Qual Health Care. 1997;9:215–9.
Gagliardi AR, Brouwers MC, Palda VA, Lemieux-Charles L, Grimshaw JM. How can we improve guideline use? A conceptual framework of implementability. Implement Sci. 2011;6:26.
Grol R, Wensing M, Eccles M, Davis D. Improving patient care. The implementation of change in health care. London: Wiley-Blackwell; 2013.
Morris AH. Developing and implementing computerized protocols for standardization of clinical decisions. Ann Intern Med. 2000;132:373–83.
Tunis SR, Hayward RSA, Wilson MC, Rubin HR, Bass EB, Johnston M, Steinberg EP. Internists’ attitudes about clinical practice guidelines. Ann Intern Med. 1994;120:956–63.
Inouye J, Kristopatis R, Stone E, Pelter M, Sandhu M, Weingarten S. Physicians’ changing attitudes toward guidelines. JGIM. 1998;13:324–6.
Gorton TA, Cranford CO, Golden WE, Walls RC, Pawelak JE. Primary care physicians’ response to dissemination of practice guidelines. Arch Fam Med. 1995;4:135–42.
Frolkis JP, Zyzanskii SJ, Schwartz JM, Suhan PS. Physician noncompliance with the 1993 National Cholesterol Education Program (NCEP-ATPII) guidelines. Circulation. 1998;98:851–5.
Choudhry NK, Fletcher RH, Soumerai SB. Systematic review: the relationship between clinical experience and quality of health care. Ann Intern Med. 2005;142:260–73.
De Carvalho FA, Schwamm LH, Kuster GW, Bueno Alves M, Cendoroglo Neto M, Sampaio SG. Get with the guidelines: stroke performance indicators in a brazilian tertiary hospital. Cerebrovasc Dis Extra. 2012;2:26–35.
Van Ganse E, Souchet T, Laforest L, Moulin P, Bertrand M, Le Jeunne P, et al. Ineffectiveness of lipid-lowering therapy in primary care. Br J Clin Pharmacol. 2005;59:456–63.
Kirchoff AC, Drum ML, Zhang JX, Schlichting J, Levie J, Harrison JF, et al. Hypertension and hyperlipidemia management in patients treated at community health centers. J Clin Outcomes Manag. 2008;15:125–31.
Renard LM, Bocquet V, Vidal-Trecan G, Lair ML, Blum-Boisgard C. Adherence to international follow-up guidelines in type 2 diabetes: a longitudinal cohort study in Luxembourg. PLoS One. 2013;8:e80162. https://doi.org/10.1371/journal.pone.0080162.
Ellrodt AG, Conner L, Riedinger M, Weingarten S. Measuring and improving physician compliance with clinical practice guidelines. A controlled interventional trial. Ann Intern Med. 1995;122:277–82.
DeRosario JM. Overcoming 10 roadblocks to initiating clinical practice guidelines. J Healthcare Quality. 1998;20:23–7.
Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PAC, Rubin HR. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282:1458–65.
Rogers EM. Difussion of innovations. New York: The Free Press; 1983.
Grilli R, Lomas J. Evaluating the message: the relationship between compliance rate and the subject of a practice guideline. Med Care. 1994;32:202–13.
Lomas J, Anderson GM, Domnick-Pierre K, Vayda E, Enkin MW, Hannah WJ. Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians. N Engl J Med. 1989;321:1306–11.
Parker DR, Gramling R, Goldman RE, Eaton CB, Ahern D, Cover RT, et al. Physician’s perceptions of barriers and facilitators regarding adoption of the National Cholesterol Education Program Guidelines. Prev Cardiol. 2008;11:29–35.
Chassin MR. Practice guidelines: best hope for quality improvement in the 1990s. J Occup Med. 1990;32:1199–206.
Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Potential benefits, limitations, and harms of clinical guidelines. BMJ. 1999;318:527–30.
Grol R. Has guideline development gone astray? Yes. BMJ. 2010;340:c306.
Woolf SH. Practice guidelines: a new reality in medicine. III. Impact on patient care. Arch Intern Med. 1993;153:2646–55.
Parmley WW. Clinical practice guidelines. Does the cookbook have enough recipes? JAMA. 1994;272:1374–5.
Dans PE. Credibility, cookbook medicine, and common sense: guidelines and the college. Ann Intern Med. 1994;120:966–8.
Annual BMA. Report of council 1987-8. Appendix V: practical guide to medical ethics. BMJ. 1988;296:40,46–7.
Berger JT, Rosner F. The ethics of practice guidelines. Arch Intern Med. 1996;156:2051–6.
Nigam A. Changing health care quality paradigms: the rise of clinical guidelines and quality measures in American medicine. Soc Sci Med. 2012;75:1933–7.
Kahn R. Guidelines: we’ll always need them, we sometimes dislike them, and we have to make them better. Diabetologia. 2010;53:2280–4.
Haynes RB, Gerstein HC. What evidence? In: Haynes RB, Gerstein HC, editors. Evidence-based diabetes care. BC Decker Inc: Hamilton; 2001.
Mountokalakis TD. Hippocrates and the essence of evidence based medicine. Hosp Chronicles. 2006;1:7–8.
Kowalski E, Chung KC. The outcomes movement and evidence based medicine in plastic surgery. Clin Plast Surg. 2013;40:241–7.
Matthews DR. Wisdom-based and evidence-based medicine. Diabetes Obes Met. 2012;14(Suppl. 1):1–2.
Cochrane AL. Effectiveness and efficiency. Random reflections on health services. London: Nuffield Hospitals Trust; 1972.
Chalmers I. The Cochrane collaboration: preparing, Maintaning, and disseminating systematic reviews of the effects of health care. Ann N Y Acad Sci. 1993;703:156–63.
Chalmers I, Dickersin K, Chalmers TC. Getting to grips with Archie Cochrane’s agenda. BMJ. 1992;305:786–8.
Sackett DL, Tugwell P, Haynes RB. Clinical epidemiology: a basic science for clinical medicine. Little, Brown and Company: Boston/Toronto; 1985.
Evidence-Based Medicine Working Group. Evidence-based medicine. A new approach to teaching the practice of medicine. JAMA. 1992;268:2420–5.
Guyatt GH, Haynes RB, Jaeschke RZ, Cook DJ, Green L, Naylor CD, et al. Users’ guides to the medical literature XXV. Evidence-based medicine: principles for applying the users’ guides to patient care. JAMA. 2000;284:1290–6.
Paauw DS. Did we learn evidence-based medicine in medical school? Some common medical mythology. In: Geyman JP, Deyo RA, Ramsey SD, editors. Evidence-based clinical practice. Concepts and approaches. Boston: Butterworth Heinemann; 2000.
Zipkin DA, Greenblatt L, Kushinka JT. Evidence-based medicine and primary care: keeping up is hard to do. Mt Sinai J Med. 2012;79:545–54.
Zwolsman SE, Te Pas E, Wieringa-de Waard M, van Dijik N, Hooft L. Barriers to GPs’ use of evidence-based medicine: knowledge and skills, attitude, and external factors. Perspect Med Educ. 2013;2:4–13.
Ioannidis JPA. Why Most published research findings are false. PLoS Med. 2005;2:0696–701.
Lohr KN. Rating the strength of scientific evidence: relevance for quality improvement programs. Int J Qual Health Care. 2004;16:9–18.
Canadian Task Force on the Periodic Health Examination: the periodic health examination. Can Med Assoc J. 1979;12:1193–254.
Herxheimer A. The Cochrane collaboration: making the results of controlled trials properly accessible. Postgrad Med J. 1993;69:867–8.
Smith R. The Cochrane collaboration at 20. Much has been achieved, but much remains to be done. BMJ. 2013;347:f7383. https://doi.org/10.1136/bmj.f7383.
United States Department of Health and Human Services, Agency of Health Care Policy and Research. Acute pain management: operative or medical procedures and trauma, 107. Clinical practice guideline No 1, AHCPR publication No 92–0023. Rockville: AHCPR; 1993.
Altman DG. Better reporting of randomized controlled trials: the CONSORT statement. BMJ. 1996;313:570–1.
The AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care. 2003;12:18–23.
Brouwers M, Kho ME, Browman GP, Cluzeau F, Feder G, Fervers B, et al, on behalf of the AGREE Next Steps Consortium. AGREE II: Advancing guideline development, reporting and evaluation in health care. Can Med Assoc J. 2010;182:E839–42.
Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. Towrds complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for reporting of diagnostic accuracy. Clin Chem. 2003;49:1–6.
Atkins D, Eccles M, Flottorp S, Guyatt GH, Henry D, Hill S, et al. Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal for existing approaches the Grade working group. BMC Health Serv Res. 2004;22:38.
Atkins D, Briss PA, Eccles M, Flottorp S, Guyatt GH, Harbour RT, et al. Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system the Grade working group. BMC Health Serv Res. 2005;23:25.
Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) Working Group. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490–4.
Stone SP, Cooper BS, Kibbler CC, Cookson BD, Roberts JA, Medley GF, et al. The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. J Antimicrob Chemother. 2007;59:833–40.
OCEBM Levels of Evidence Working Group. The Oxford 2011 Levels of Evidence. Accessed 16 June 2014 at: http://www.cebm.net/.
Graham R, Mancher M, Wolman DM, Greenfield S, Steinberg E, editors. Clinical practice guidelines we can trust. Washington, D.C.: National Academies Press; 2011.
Greenhalgh T, Wong G, Westhorp G, Pawson R. Protocol-realist and meta-narrative evidence synthesis: evolving standards (RAMESES). BMC Med Res Methodol. 2011;11:115.
WHO handbook for guideline development. Geneva: World Health Organization; 2012.
Agency for Healthcare Research and Quality (AHRQ). Center for Evidence and Practice Improvement (CEPI). Accessed 11 Aug 2014, at http://ahrq.gov/cpi/centers/cepi/index.html.
Luder AS. Evidence-based clinical practice guidelines: what is the evidence? IMAJ. 2011;13:689–71.
The Joint National Committee on Detection. Report of the joint National Committee on detection, evaluation and treatment of high blood pressure. A cooperative study. JAMA. 1977;237:255–61.
The Joint National Committee on Detection. The 1980 report of the joint National Committee on detection, evaluation and treatment of high blood pressure. Arch Intern Med. 1980;140:1280–5.
The Joint National Committee on Detection. The 1984 report of the joint National Committee on detection, evaluation and treatment of high blood pressure. Arch Intern Med. 1984;144:1045–57.
The Joint National Committee on Detection. The 1988 report of the joint National Committee on detection, evaluation and treatment of high blood pressure. Arch Intern Med. 1988;148:1023–38.
The Joint National Committee on Detection. The fifth report of the joint National Committee on detection, evaluation and treatment of high blood pressure. Arch Intern Med. 1993;153:154–83.
The Joint National Committee on Detection. The sixth report of the joint National Committee on detection, evaluation and treatment of high blood pressure. Arch Intern Med. 1997;157:2413–46.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The seventh report of the joint National Committee on detection, evaluation and treatment of high blood pressure. The JNC 7 report. JAMA. 2003;289:2560–72.
James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults. Report from the Panel Members Appointed by The Eight Joint National Committee (JNC 8). JAMA. 2014;311:507–20.
Rodriguez-Saldana J. The components in the improvement of quality of health care. In Rodriguez-Saldana J: Quality of health care, from evidence to implementation. New York: Nova Publishers; 2015.
Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison EJ, et al. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and Management of High Blood Pressure in adults: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2018;71(19):e127–248. https://doi.org/10.1016/j.jacc.2017.11.006.
Hypertension. Hypertension 2017 Guideline Data Supplements 1–283. Downloaded on December 12, 2017.
American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 1989;12:365–8.
Expert Committee of the Canadian Diabetes Advisory Board. Clinical practice guidelines for treatment of diabetes mellitus. Can Med Assoc J. 1992;147:697–712.
American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 2002;25:S33–49.
Canadian Task Force on the Periodic Health Examination. The periodic health examination. CMA J. 1979;121:1193–254.
Nathan DM, Buse JB, Heine RJ, Holman RR, Sherwin R, Zinman B. Management of Hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care. 2006;29:1963–72.
Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B. Medical Management of Hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care. 2009;32:193–203.
American Diabetes Association. Glycemic targets: standards of medical Care in Diabetes 2018. Diabetes Care. 2018;41(Suppl 1):S55–64.
Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Targets of Glycemic control. Can J Diabetes. 2013;37:S31–4.
National Institute of Clinical Excellence NICE. Type 2 diabetes in adults. NICE guideline. Published 2 December 2015. nice.org.uk/guidance/ng28. Downloaded on February 27, 2018 at https://www.nice.org.uk/guidance/ng28.
Weng J, Ji L, Jia W, Lu J, Zhou Z, Zou D, et al. Standards of care for type 2 diabetes in China. Diabetes Metab Res Rev. 2016;32:442–58.
International Diabetes Federation. Recommendations for Managing Type 2 Diabetes in Primary Care 2017. www.idf/managing-type2-diabetes.
Royal Australian College of General Practitioners. Diabetes Australia. General Practice Guideline of Type 2 Diabetes 2016–2018.
Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA. Consensus statement by the American Association of Clinical Endocrinologists and American College of endocrinology on the comprehensive type 2 diabetes management algorithm - 2018 executive summary. Endocr Pract. 2018;24:91–120.
Qaseem A, Wilt TJ, Kansagara D, Horwitch C, Barry MJ, Forciea MA. Hemoglobin A1c targets for Glycemic control with pharmacologic therapy for nonpregnant adults with type 2 diabetes mellitus: a guidance statement update from the American college of physicians. Ann Intern Med. 2018;168(8):569–76. https://doi.org/10.7326/M17-0939.
Ganda OP, Gabbay RA. Evidence-based diabetes management. Joslin Diabetes Center clinical guidelines. Am J Manag Care. 2018;24:SP203–62.
Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of Hyperglycemia in type 2 diabetes: a patient-Centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of diabetes (EASD). Diabetes Care. 2012;35:1364–79.
Gerstein HC, Miller ME, Byington RP, et al. Action to control cardiovascular risk in diabetes study group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545–59.
Patel A, MacMahon S, Chalmers J, et al. ADVANCE collaborative group. Intensive blood glucose control and macrovascular outcomes in type 2 diabetes. N Engl J Med. 2008;358:2560–72.
Turnbull FM, Abraira C, Anderson RJ, Byington RP, Chalmers JP, Duckworth WC, et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia. 2009;52:2288–98.
Raz I, Riddle MC, Rosenstock J, Buse JB, Inzucchi SE, Home PD, et al. Personalized Management of Hyperglycemia in type 2 diabetes. Diabetes Care. 2013;36:1779–88.
Mülhauser I, Meyer G. Evidence base in guideline generation in diabetes. Diabetologia. 2013;56:1201–9.
Kuehn BM. IOM sets out “gold standard” practices for creating guidelines, systematic reviews. JAMA. 2011;305:1846–8.
Ransohoff M, Pignone M, Sox HC. How to decide whether a clinical practice guideline is trustworthy. JAMA. 2013;309:139–40.
Vigersky RA. A review and critical analysis of professional societies´ guidelines for pharmacologic Management of Type 2 diabetes mellitus. Curr Diab Rep. 2012;12:246–54.
Grant RW, Kirkman MS. Trends in the evidence level of the American Diabetes Association’s “standards of medical Care in Diabetes” from 2005 to 2014. Diabetes Care. 2015;38:6–8.
Bouchonville MF, Matani S, DuBroff JJ, DuBroff RJ. Are diabetes guidelines truly evidence based? Diabetes Res Clin Pract. 2017;127:70–9.
Kruse BC, Vassar BM. Unbreakable? An analysis of the fragility of randomized trials that support diabetes treatment guidelines. Diabetes Res Clin Pract. 2017;134:91–105.
LeFevre M. From authority to evidence-based medicine: are clinical practice guidelines moving us forward or backward? Ann Fam Med. 2017;15:410–2.
Bennett WL, Odelola OA, Wilson LM, Bolen S, Selvaraj S, Robinson KA, et al. Evaluation of guideline recommendations on oral medications for type 2 diabetes mellitus: a systematic review. Ann Intern Med. 2012;156:27–36.
Anwer MA, Al-Fahed O, Arif SI, Amer YS, Titi MA, Al-Rukban MO. Quality assessment of recent evidence-based clinical practice guidelines for management of type 2 diabetes mellitus in adults using the AGREE II instrument. J Eval Clin Pract. 2018;24(1):166–72.
Radwan M, Akbari Sari A, Rashidian A, Takian A, Abou-Dagga S, Elsous A. Appraising the methodological quality of the clinical practice guidelines for diabetes mellitus using the AGREE II instrument: a methodological evaluation. J R Soc Med Open. 2017;8:1–8.
El-Kebbi IM, Ziemer DC, Musey VC, Gallina DL, Phillips LS. Diabetes in urban African-Americans. IX. Provider adherence to management protocols. Diabetes Care. 1997;20:698–703.
Fantini MP, Compagni A, Rucci A, Mimmi S, Longo F. General practitioners´ adherence to evidence-based guidelines: a multilevel analysis. Health Care Manag Rev. 2012;37(1):67–76.
Birrenbach T, Kraehenmann S, Perrig M, Berendonk C, Huwendiek S. Physicians’ attitudes toward use of, and perceived barriers to clinical guidelines: a survey among Swiss physicians. Adv Med Educ Pract. 2016;7:673–80.
Bryant W, Greenfield JR, Chisholm DJ, Campbell LV. Diabetes guidelines: easier to preach than to practice? MJA. 2006;185:305–9.
Barth JH, Misra S, Aakre KM, Langlois MR, Watine J, Twomey PJ, Oosterhuis WP. Why are clinical practice guidelines not followed? Clin Chem Lab Med. 2016;54:1133–9.
Benjamin EM, Schneider MS, Hinchey KT. Implementing practice guidelines for diabetes care using problem-based learning. Diabetes Care. 1999;22:1672–8.
Kirkman MS, Williams SR, Caffrey HH, Marrero DG. Impact of a program to improve adherence to diabetes guidelines by primary care physicians. Diabetes Care. 2002;25:1946–51.
Pruthu TK, Majella MG, Nair D, Ramaswamy G, Palanivel C, Subitha L, et al. Does audit improve diabetes care in a primary care setting? A management tool to address health system gaps. J Nat Sci Biol Med. 2015;6:S58–62.
Marahrens L, Röck D, Ziemssen T, Kern R, Ziemssen F, Fritsche A. Implementation of the National Guidelines for the treatment of diabetes mellitus type 2 in secondary diabetes centers. Dtsch Med Wochenschr. 2017;142:e131–9.
Gaede P, Vedel P, Parving HH, Pedersen O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomized trail. Lancet. 1999;353:617–22.
Gaede P, Valentine WJ, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383–93.
Gaede P, Lund-Andersen H, Parving HR, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358:580–91.
Gaede P, Oellgaard J, Carstensen B, Rossing P, Lund-Andersen H, Parving HH, et al. Years of life gained by multifactorial intervention in patients with type 2 diabetes and microalbuminuria: 21 years follow-up on the Steno-2 randomized trial. Diabetologia. 2016;59:2298–307.
Gaede P, Valentine WJ, Palmer AJ, Tucker DM, Lammert M, Parving HH, et al. Cost-effectiveness of intensified versus conventional multifactorial intervention in type 2 diabetes: results and projections from the Steno-2 study. Diabetes Care. 2008;31:1510–5.
Pimazoni-Netto A, Zanella MT. Diabetes guidelines may delay timely adjustments during treatment and might contribute to clinical inertia. Diabetes Technol Ther. 2014;16:768–70.
Reach G, Pechtner V, Gentilella R, Corcos A, Ceriello A. Clinical inertia and its impact on treatment intensification in people with type 2 diabetes mellitus. Diabetes Metab. 2017;43:501–11.
Armstrong MJ, Bloom JA. Patient involvement in guidelines is poor five years after institute of medicine standards: review of guideline methodologies. Res Involv Engagem. 2017;3:19.
Hale K, Capra S, Bauer J. Are nutrition messages lost in transmission? Assessing the quality and consistency of diabetes guideline recommendations on the delivery of nutrition therapy. Patient Educ Couns. 2016;99:1940–6.
Piette JD, Kerr EA. The impact of comorbid chronic conditions on diabetes care. Diabetes Care. 2006;29:725–31.
Hughes LD, McMurdo ET, Guthrie B. Guidelines for people not for diseases: the challenges of applying UK clinical guidelines to people with multimorbidity. Age Ageing. 2013;42:62–9.
American Diabetes Association. 3. Comprehensive medical evaluation and assessment of comorbidities: standards of medical Care in Diabetes – 2018. Diabetes Care. 2018;41(Suppl 1):S28–37.
Ceriello A, Gallo M, Candido R, De Micheli A, Esposito K, Gentile S, Medea G. Personalized therapy algorithms for type 2 diabetes: a phenothype-based approach. Pharmacogenomics Pers Med. 2014;7:129–36.
Conlin PR, Colburn J, Aron D, Pries RM, Tschanz MP, Pogach L. Synopsis of the 2017 U.S. Department of Veterans Affairs/U.S. Department of Defense clinical practice guideline: Management of Type 2 diabetes mellitus. Ann Intern Med. 2017;167:655–63.
Abbate SL. Expanded ABCs of diabetes. Clin Diabetes. 2003;21:128–33.
Schimke KE, Renström F, Meier S, Stettler C, Brändle M. Compliance with guidelines for disease management in diabetes: results from the Swiss Diab registry. BMJ Open Res Care. 2018;6:e000454. https://doi.org/10.1136/bmjdrc-2017-000454.
Harris SB, Stewart M, Brown JB, Wetmore S, Faulds C, Webster-Bogaert S, Porter S. Type 2 diabetes in family practice. Room for improvement. Can Fam Physician. 2003;49:778–85.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Rodriguez-Saldana, J. (2019). Clinical Practice Guidelines, Evidence-Based Medicine, and Diabetes. In: Rodriguez-Saldana, J. (eds) The Diabetes Textbook. Springer, Cham. https://doi.org/10.1007/978-3-030-11815-0_21
Download citation
DOI: https://doi.org/10.1007/978-3-030-11815-0_21
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-11814-3
Online ISBN: 978-3-030-11815-0
eBook Packages: MedicineMedicine (R0)